CCR2 and central nervous system cancer: The lack of effect observed following the implantation of individual CCL2 or CCL7 knockdown gliomas suggested a potential chemokine ligand redundant mechanism utilized by the KR158B cells to recruit CCR2+/CX3CR1+ cells to the TME.